1-155066888-C-T

Variant summary

Our verdict is Uncertain significance.
0 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 0 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_SupportingB3_Supporting

The NM_005227.3(EFNA4):c.272C>T (p.Pro91Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene EFNA4 is a known oncogene (CancerMine: 4 oncogene citations). The variant allele was found at a cumulative frequency of 0.00000372 (AC=6) in the gnomAD database across 1,614,034 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000488. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

EFNA4
NM_005227.3 missense

Scores

7
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.38

Publications

0 publications found
Variant links:
Genes affected
EFNA4 (HGNC:3224): (ephrin A4) This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin that has been implicated in proliferation and metastasis of several types of cancers. [provided by RefSeq, May 2022]
EFNA4 Gene-Disease associations (from GenCC):
  • craniosynostosis
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005227.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 0 points.

O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000005 — very rare (O3 supporting [+1])
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_005227.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

EFNA4 NM_005227.3
MANE Select
HGVSc / HGVSpc.272C>Tp.Pro91Leu
Exon rankExon 2 of 4
missense
Prot: NP_005218.1UniProt: P52798-1
EFNA4 NM_182689.2
HGVSc / HGVSpc.272C>Tp.Pro91Leu
Exon rankExon 2 of 4
missense
Prot: NP_872631.1UniProt: P52798-3
EFNA4 NM_182690.3
HGVSc / HGVSpc.272C>Tp.Pro91Leu
Exon rankExon 2 of 4
missense
Prot: NP_872632.2UniProt: P52798-2

Ensembl Transcripts

EFNA4 ENST00000368409.8
TSL:1MANE Select
HGVSc / HGVSpc.272C>Tp.Pro91Leu
Exon rankExon 2 of 4
missense
Prot: ENSP00000357394.3UniProt: P52798-1
EFNA4 ENST00000359751.8
TSL:1
HGVSc / HGVSpc.272C>Tp.Pro91Leu
Exon rankExon 2 of 4
missense
Prot: ENSP00000352789.4UniProt: P52798-2
EFNA4-EFNA3 ENST00000505139.1
TSL:2
HGVSc / HGVSpc.113+2952C>T
Exon rankIntron 1 of 4
intron
Prot: ENSP00000426741.1UniProt: K9J7H7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.0000131
AC:2
Hom:0
AN:152254
Cov:32
GnomAD4 exome
AF: 0.00000274
AC:4
Hom:0
AN:1461780
Cov:32
GnomAD4 genome
Warning
AF: 0.0000131
AC:2
Hom:0
AN:152254
Cov:32
TOPMed (Bravo)
AF: 0.00000378
AC:1
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:13470
Showing 5 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.0000352 128420 0.00 028844
SCHEMA
(Schizophrenia)
0.0000129 177664 0.00 0139302
Showing 2 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational Scores

AlphaGenome AVI
Uncertain15
AlphaMissense
Benign0.11
BayesDel_addAF
Uncertain0.031T
BayesDel_noAF
Benign-0.19
CADD
Benign19
DANN
Uncertain0.97
DEOGEN2
Uncertain0.51D
Eigen
Benign-0.44
Eigen_PC
Benign-0.47
FATHMM_MKL
Benign0.17N
FuncVEP CTI
Benign0.097
GPN-Star LLR
N/A-4.8
GPN-Star score
N/A4.8
LIST_S2
Benign0.81T
M_CAP
Uncertain0.098D
MetaRNN
Benign0.22T
MetaSVM
Uncertain0.015D
Mutation Taster
N/A94/6polymorphism
MutationAssessor
Uncertain2.4M
PhyloP100
Benign1.4
popEVE
Benign-3.5
PROVEAN
Benign-1.8N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.1
REVEL
Benign0.28
Sift
Uncertain0.0040D
Sift4G
Benign0.095T
Varity_R
N/A0.11
VESM-3B
Benign-6.8
Showing 29 of 29 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.